MedTrace Logo

RECTOSACROUTEROPEXY vs. WELLS

NCT07673406 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-06-29

No results posted yet for this study

Summary

The goal of this clinical trial was to compare two surgical techniques in female patients with full-thickness rectal prolapse. The main questions it aimed to answer were:

1. Does modified rectosacrouteropexy with pelvic peritonization improve postoperative anatomical outcomes compared with conventional Wells rectopexy?
2. Does modified rectosacrouteropexy with pelvic peritonization improve postoperative functional outcomes compared with conventional Wells rectopexy?

Researchers compared modified rectosacrouteropexy with pelvic peritonization with conventional Wells rectopexy to assess postoperative recurrence, complications, anorectal manometry, defecography findings, and pelvic floor symptom scores. Participants underwent one of the assigned surgical procedures and were followed after surgery with clinical assessment and pelvic floor function testing.

Conditions

  • Rectal Prolapse
  • Pelvic Organ Prolapse (POP)

Interventions

PROCEDURE

Modified rectosacrouteropexy

Surgical treatment for full-thickness rectal prolapse using modified rectosacrouteropexy with pelvic peritonization.

PROCEDURE

Wells rectopexy

Conventional surgical rectopexy procedure for full-thickness rectal prolapse

Sponsors & Collaborators

  • Azerbaijan Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
47 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2026-05-15
Completion
2028-01-31

Countries

  • Azerbaijan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07673406 on ClinicalTrials.gov